Success across the board for C4X Discovery Holdings plc and its partnerships
Drug discovery company C4X Discovery Holdings plc released a report today (August 2) detailing the continued…
Drug discovery company C4X Discovery Holdings plc released a report today (August 2) detailing the continued…
Enterome, a clinical stage biopharmaceutical company developing immunomodulatory drugs based on its bacterial Mimicry drug…
Artificial intelligence will be used to perform molecular analysis of biopsies from unidentified Inflammatory Bowel…
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed…
Upstream Bio, a U.S. biotech company focused on inflammation, today exited stealth mode with $200M…
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two…
The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll…
The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by…
New, more targeted treatments are on the horizon for the rare autoimmune disease ANCA-associated vasculitis,…
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs…
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…